Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

22 questions · 27 findings · 2 reviews

No studies found 10 · 37%GRADE not reported 0 · 0%Very low 1 · 3.7%Low 4 · 14.8%Moderate 11 · 40.7%High 1 · 3.7%

tDCS vs placebo or control

Secondary outcome measure: cognitive abilities at the end of · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke

The review found no eligible studies for this question.

1 finding from 1 review

tDCS vs active control

Secondary outcome measure: cognitive abilities at the end of · people with stroke

The review found no eligible studies for this question.

2 findings from 1 review

tDCS vs placebo or control

Secondary outcome measure: mean upper extremity function at the end of the intervention periodClinical measures of upper extremity function. Scale from: 0 to infinity. · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke
1 finding from 1 review

tDCS vs placebo or control

Secondary outcome measure: lower extremity function at the end of · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke

The review found no eligible studies for this question.

1 finding from 1 review

tDCS vs placebo or control

Secondary outcome measure: hemispatial neglect at the end of · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke

The review found no eligible studies for this question.

1 finding from 1 review

tDCS vs active control

Secondary outcome measure: lower extremity function at the end of · people with stroke
2 findings from 1 review

tDCS vs active control

Muscle strength · people with stroke
2 findings from 1 review

tDCS vs active control

Dropouts, adverse events and deaths during intervention phase Numbers of dropouts, adverse events and deaths from all causes · people with stroke

tDCS showed no clear difference in secondary outcome measure: dropouts, adverse events and deaths… compared with any type of active control intervention (moderate certainty).

1 finding from 1 review

tDCS vs active control

ADL outcome · people with stroke

The review found no eligible studies for this question.

2 findings from 1 review

tDCS vs active control

Secondary outcome measure: mean upper extremity function at the end of the intervention periodClinical measures of upper extremity function. Scale from: 0 to infinity. · people with stroke
2 findings from 1 review